Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK
Procarbazine 50mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsules with white opaque cap and body. Marked ‘CL50’ on one half. |
Each capsule contains 58.3mg Procarbazine hydrochloride (equivalent to 50mg of Procarbazine).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ibenzmethyzine |
Procarbazine, a methylhydrazine derivative, is a cytostatic agent with weak MAO inhibitor properties. Its exact mode of action on tumour cells is unknown. |
| List of Excipients |
|---|
|
Mannitol Capsule shell components: Gelatin Ink components: Shellac |
Blister packs of 50 capsules.
Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK
PL 16853/0114
30/08/2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
